Discovery of Potent and Selective Leads against Toxoplasma gondii Dihydrofolate Reductase via Structure-Based Design

[Image: see text] Current treatment of toxoplasmosis targets the parasite’s folate metabolism through inhibition of dihydrofolate reductase (DHFR). The most widely used DHFR antagonist, pyrimethamine, was introduced over 60 years ago and is associated with toxicity that can be largely attributed to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:ACS Med Chem Lett
Main Authors: Welsch, Matthew E., Zhou, Jian, Gao, Yueqiang, Yan, Yunqing, Porter, Gene, Agnihotri, Gautam, Li, Yingjie, Lu, Henry, Chen, Zhongguo, Thomas, Stephen B.
Format: Artigo
Jezik:Inglês
Izdano: American Chemical Society 2016
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5150685/
https://ncbi.nlm.nih.gov/pubmed/27994750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.6b00328
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki